Novo-Helisen-Depot(NHD)

螨变应原注射液

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNovo-Helisen-Depot(NHD)
Drug Alias Name阿罗格
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRhinitis, AllergicAsthma
Global Approved IndicationsRhinitis, AllergicAsthma
Approved Indications in ChinaRhinitis, AllergicAsthma
Original Approved Country/TerritoryMainland China
Original Approved Date2015/07/02
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergopharma Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsRhinitis, AllergicAsthma
Inactive IndicationsN/A

Other Information

ATC CodeV01AA03
Related LinksN/A